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This Month in the Journal
This month in the Journal, van Bokhoven and Brunner
(p. 1) discuss p63, a key regulator of limb, epithelial, and
craniofacial development. Mutations in TP63, the gene
encoding p63, are involved in a variety of malformation
syndromes, including limb-mammary syndrome, acro-
dermato-ungual-lacrimal-tooth syndrome, ectrodactyly–
ectodermal dysplasia–clefting syndrome, ankyloblepha-
ron–ectodermal dysplasia–clefting syndrome, and non-
syndromic split-hand/split-foot malformation. Along with
an outline of what is known about p63 activity and its
role in mammalian embryonic development, the authors
cover genotype-phenotype correlations and give insight
into how one gene can lead to a spectrum of disorders.
Elastin Deficiency and Cell Proliferation, by Urba´n et
al. (p. 30)
Patients with supravalvular aortic stenosis and Williams-
Beuren syndrome have occluded arteries as a result of
either point mutations in or deletions of the elastin gene.
Regions of the aorta in these patients have an abnor-
mally thick wall diameter, because of an increase in the
smooth-muscle cell layers in these areas. Urba´n et al.
uncover a connection between the genetic and physical
abnormalities in these patients. They find that defects in
the elastin gene result in lower elastin mRNA levels and
in decreased deposition of insoluble elastin from cells of
patients. These properties are associated with increased
proliferation, in culture, of confluent smooth-muscle
cells and fibroblasts. Supplementation of the cells with
insoluble elastin decreases their proliferation rate, so it
seems that elastin itself has an antiproliferative effect.
Excessive cell proliferation in the walls of the aorta could
lead to the increased number of cell layers and disor-
ganized architecture that are seen on histological ex-
amination of aortas from affected individuals.
AE Is Due to Effects in a Novel Zinc Transporter, by
K. Wang et al. (p. 66)
Acrodermatitis enteropathica (AE) is a zinc-absorption
deficiency that manifests with a variety of symptoms,
including alopecia, immune-system dysfunction, failure
to thrive, dermatitis, and diarrhea. It has been hypoth-
esized that affected individuals are deficient for a binding
factor that transports dietary zinc to epithelial cells, and
Wang et al. believe that they have determined the identity
of this factor. This protein, hZIP4, is a novel transmem-
brane protein related to a family of protein sequences,
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some of which transport zinc. hZIP4 is expressed abun-
dantly in the small intestine, stomach, colon, and kidney
and is localized to the apical surface of enterocytes in
mouse colon. Missense mutations, a splice-site mutation,
and an upstream deletion were found in the encoding
gene in individuals with AE. Because dietary zinc sup-
plementation is an effective therapy for AE, the authors
speculate that either (1) the mutant hZIP4 has only a
partial loss of function that can be overcome by excess
zinc or (2) another zinc transporter can supplement the
activity of hZIP4, to compensate for the defect.
Large Deletions in Kindreds with Autism, by Yu et al.
(p. 100)
In the course of searching for autism-susceptibilitygenes,
Yu et al. discovered four interstitial deletions, ranging
in size from 5 kb to 1260 kb, in 12 families with autistic
siblings. One of the deletions, a 192-kb deletion on chro-
mosome 8, appears to be a polymorphism, because it is
found in a variety of control populations. In fact, the
deletion allele is more common in control subjects than
in autistic individuals. The other three deletions are re-
stricted to families with autism, but they are not identical
in each family and they do not segregate perfectly with
the disease. The authors propose a couple of scenarios
that could explain the association between these dele-
tions and autism. One scenario is that the deletions are
autism-susceptibility alleles. Unfortunately, no gene of
known function is disrupted by the deletions. An alter-
native hypothesis is that alleles at autism-susceptibility
loci cause deletions and rearrangements, possibly be-
cause of increased meiotic error. In this case, the dele-
tions would be not the cause but, rather, a consequence
of autism-susceptibility alleles located elsewhere.
Microcephalin: Mutated in MCPH1 Microcephaly, by
Jackson et al. (p. 136)
Jackson et al. have uncovered the first gene for primary
microcephaly, a disorder in which affected individuals
have a small head circumference, resulting from a
smaller-than-normal brain. A nonsense mutation was
identified in two affected families, and it is predicted to
severely truncate the encoded protein. This previously
undescribed protein, dubbed “microcephalin” by the au-
thors, contains three BRCA1 C-terminal (BRCT) do-
mains, which are known to interact with each other, with
other proteins, and with DNA at double-strand breaks.
In situ hybridizations to detect the mouse ortholog in
fetal mouse brain indicates that microcephalin is ex-
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pressed at high levels in the developing forebrain, par-
ticularly in the lateral ventricles, where neurons that will
form the cerebral cortex are produced. Because proteins
with BRCT domains are known to be involved in cell-
cycle regulation and in DNA repair, the authors spec-
ulate on mechanisms by which a defect in these activities
may be involved in microcephaly, should microcephalin
itself be found to have these functions.
Parent-of-Origin Effect in Retinoblastoma (Report), by
Klutz et al. (p. 174)
Klutz et al. present two interesting families with parent-
of-origin–dependent penetrance of an RB1 mutation, a
phenomenon that has not been reported previously for
retinoblastoma. These unrelated families possess the
same splice-site mutation, but on different haplotype
backgrounds. Individuals who inherit the mutation from
their fathers are much more likely to have retinoblas-
toma than are individuals with a maternally inherited
mutation. The mutation alters a splice site and causes
exon 6 to be skipped, leading to a frameshift and pre-
mature truncation of the encoded protein. Analysis of
RNA from individuals with a maternally inherited mu-
tation indicates that they have approximately equal
amounts of wild-type and mutant RB1 transcript. In
contrast, those with paternally inherited mutations have
much less mutant transcript, relative to wild-type tran-
script. The correlation between a reduced level of mutant
transcript and disease suggests that the shorter transcript
may have residual function, although a truncated protein
was not detected by western blot. Increased relative
abundance of the mutant transcript after treatment with
an inhibitor of nonsense-mediated decay indicates that
this process may play a role in the reduction of the mu-
tant-transcript levels, but the full explanation behind the
parent-of-origin–dependent penetrance in these families
is not yet clear.
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